Your browser doesn't support javascript.
loading
Plasmid-based CRISPR-Cas9 system efficacy for introducing targeted mutations in CD81 gene of MDA-MB-231 cell line.
Arbabi Zaboli, Kasra; Rahimi, Hossein; Thekkiniath, Jose; Taromchi, Amir Hossein; Kaboli, Saeed.
Afiliação
  • Arbabi Zaboli K; Department of Medical Biotechnology, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.
  • Rahimi H; Department of Medical Biotechnology, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.
  • Thekkiniath J; Fuller Laboratories, Fullerton, CA, USA.
  • Taromchi AH; Department of Medical Biotechnology, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.
  • Kaboli S; Cancer Gene Therapy Research Center, Zanjan University of Medical Sciences, Zanjan 4513956111, Iran. kaboli2009@gmail.com.
Folia Histochem Cytobiol ; 60(1): 13-23, 2022.
Article em En | MEDLINE | ID: mdl-35157300
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sistemas CRISPR-Cas / Edição de Genes Limite: Female / Humans Idioma: En Revista: Folia Histochem Cytobiol Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sistemas CRISPR-Cas / Edição de Genes Limite: Female / Humans Idioma: En Revista: Folia Histochem Cytobiol Ano de publicação: 2022 Tipo de documento: Article